About Cronus Pharma Specialities India Private Limited
Data last updated:
Cronus Pharma Specialities India Private Limited is a private limited company based in Hyderabad, Telangana, India, a subsidiary of Cronus Pharma Mauritius. It operates in the chemical products segment of the chemicals sector. It was incorporated on 02 September 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2015PTC100543. Its GSTIN is 36AAGCC2922E1Z0 (Telangana).
The company has an authorised share capital of ₹190 Cr and a paid-up capital of ₹119.11 Cr. It is led by directors Mallemputi Ramakrishna Chowdary and Kavuru Vimal Kumar.
Its last annual general meeting (AGM) was held on 21 July 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Unit 26/B 19th Floor The Headquarters Orbit, Plot No 30/C Sy No 83/1 Hyderabad Knowledge City Raidurg Serilingampally Mandal, Telangana, India – 500081.
As per the financials filed for FY 2025, the company reported a revenue of ₹484.74 Cr, a growth of 64% compared to the previous year. For the same year it recorded a net profit of ₹79.74 Cr (net margin 16.4%) and EBITDA of ₹153.71 Cr (EBITDA margin 31.7%). Revenue has grown at a compounded annual rate (CAGR) of 47% over three years and 133% over five years.
The company has about 272 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Cronus Pharma Specialities India. As per MCA filings, the company has open charges of ₹297 Cr on record. The company has 5 deals on record (3 rights issues, 1 funding round, 1 secondary share transfer), with disclosed funding of ₹98.39 Cr; the latest was in May 2022. Its 6 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 4 smaller; the largest is Maneesh Pharmaceuticals Limited with revenue of ₹534.48 Cr. The company has 12 MSME Form 1 returns on record between 2019 and 2024, listing 173 overdue payments to 15 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website cronuspharma.com.
Company details
Contact details
Cronus Pharma Specialities India Private Limited's registered office is in Hyderabad, Telangana. Its website is cronuspharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressUnit 26/B 19th Floor The Headquarters Orbit, Plot No 30/C Sy No 83/1 Hyderabad Knowledge City Raidurg Serilingampally Mandal, Telangana, India – 500081
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
To see the full contact details of Cronus Pharma Specialities India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Cronus Pharma Specialities India operates one associated brand: Cronus Pharma Specialities India. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| A generic veterinary pharmaceutical company developing and manufacturing animal health products. | cronuspharma.com |
Business activity
The main business activities of Cronus Pharma Specialities India are manufacturing and professional, scientific and technical. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and scientific research and development. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Cronus Pharma Specialities India Private Limited, buy the company report.
Financials of Cronus Pharma Specialities India Private Limited
FY 2025 filings availableCronus Pharma Specialities India Private Limited reported revenue of ₹484.74 Cr (up 64% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 133% over five years, including 64% growth in the latest year. EBITDA rose 116% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹153.71 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹79.74 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 31.7% | ||||
| Net Profit Margin | 16.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cronus Pharma Specialities India Private Limited, buy the company report.
Board of directors of Cronus Pharma Specialities India Private Limited
Cronus Pharma Specialities India has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mallemputi Ramakrishna Chowdary Also directs: Gensource Pharma Solutions Private Limited, Cronus Vetcare Private Limited, Cronus Foundation and 1 more | Director | 02 Sep 2015 | 11 Years 2 Months | Current |
| Kavuru Vimal Kumar Also directs: Citron Realty LLP, Gensource Pharma Solutions Private Limited, Cronus Vetcare Private Limited and 5 more | Director | 16 Jul 2018 | 8 Years 3 Months | Current |
Peer comparison
Cronus Pharma Specialities India Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Maneesh Pharmaceuticals Limited | ₹534.48 Cr (FY 2022) | 28.0% | Mumbai, Maharashtra, India | |||
| Mapaex Health and Personalcare Private Limited | ₹514.15 Cr (FY 2024) | 23.0% | Bhopal, Madhya Pradesh, India | |||
| Cronus Pharma Specialities India Private Limitedthis company | ₹484.74 Cr (FY 2025) | ₹79.74 Cr | 16.4% | 64.0% | 272 | Hyderabad, Telangana, India |
| Syncom Formulations (India) Limited | ₹482.45 Cr (FY 2025) | 74.0% | Mumbai, Maharashtra, India | |||
| Karnataka Antibiotics and Pharmaceuticals Limited | ₹479.24 Cr (FY 2022) | 11.0% | Bangalore, Karnataka, India | |||
| Cachet Pharmaceuticals Private Limited | ₹478.02 Cr (FY 2025) | 6.0% | Patna, Bihar, India | |||
| Adcock Ingram Limited | ₹463.95 Cr (FY 2025) | 8.0% | Bangalre, Karnataka, India |
To see the full peer comparison of Cronus Pharma Specialities India Private Limited, buy the company report.
Auditor
Cronus Pharma Specialities India Private Limited is audited by K.Nagaraju and Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K.Nagaraju and Associates | FY 2023 | 002270S |
Shareholding
The shareholding of Cronus Pharma Specialities India Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Cronus Pharma Specialities India Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 12 Sep 2025 | 101158378 | Others | ₹48 Cr | Open | |
| 31 Oct 2018 | 100218460 | Others | ₹249 Cr | Open |
To see the full charge records of Cronus Pharma Specialities India Private Limited, buy the company report.
Total charge records: 2 View all charges
Deals & funding
Cronus Pharma Specialities India Private Limited has 5 deals on record (3 rights issues, 1 funding round, 1 secondary share transfer), with disclosed funding of ₹98.39 Cr; the latest was in May 2022.
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| May 2022 | Rights issue | ₹152.78 Cr | Investors: Cronus Pharma Mauritius |
| Jul 2021 | Rights issue | ₹22.35 Cr | Investors: Cronus Pharma Mauritius |
| Aug 2019 | Rights issue | ₹5.65 Cr | Investors: Cronus Pharma Mauritius |
| Mar 2017 | Funding round | ₹98.39 Cr | Investors: Cronus Pharma Mauritius |
| Mar 2017 | Secondary share transfer | Undisclosed | Buyer: Cronus Pharma Mauritius Seller: Citzen Pharmaceuticals LLC |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Cronus Pharma Specialities India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
Credit ratings & regulatory alerts
Cronus Pharma Specialities India Private Limited was last rated by Care on 04 Oct 2021.
| Rating agency | Rated on | Rating |
|---|---|---|
| Care | 04 Oct 2021 |
To see the full credit ratings and regulatory alerts of Cronus Pharma Specialities India Private Limited, buy the company report.
MSME payment delays
Cronus Pharma Specialities India Private Limited has 12 MSME Form 1 returns on record between 2019 and 2024, listing 173 overdue payments to 15 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 15)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Himedia Laboratories Private Limited | |||
| Kinelectro Lines India Private Limited | |||
| E Scientia Laboratory Essentials | |||
| Klenzaids Contamination Controls Private Limited | |||
| an individual supplier |
To see the full MSME payment records of Cronus Pharma Specialities India Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Cronus Pharma Specialities India Private Limited has a workforce of 272 employees on its EPFO records as of May 10, 2024, across 1 active EPFO establishment.
GST
Cronus Pharma Specialities India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAGCC2922E1Z0 | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Cronus Pharma Specialities India Private Limited, buy the company report.
Recent activity
Cronus Pharma Specialities India Private Limited has 7 board changes on record since 2015: 3 appointments and 4 cessations. The latest: Muralikrishna Prasad Vallabhaneni ceased to be Additional Director on 29 Sep 2024.
1 earlier event is in the company report.
Frequently asked questions
Cronus Pharma Specialities India is an active private limited company based in Hyderabad, Telangana, India. The company works in chemical products, within the chemicals industry. It was incorporated on 02 September 2015 (11+ years old) and is registered under CIN U24232TG2015PTC100543.
Cronus Pharma Specialities India has 2 current directors:
- Mallemputi Ramakrishna Chowdary - Director
- Kavuru Vimal Kumar - Director
The latest financial statements of Cronus Pharma Specialities India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 21 July 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Cronus Pharma Specialities India is 36AAGCC2922E1Z0, registered in Telangana.
The CIN (Corporate Identification Number) of Cronus Pharma Specialities India is U24232TG2015PTC100543. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cronus Pharma Specialities India was incorporated on 02 September 2015, making it 11+ years old. It is registered with the Registrar of Companies, Hyderabad.
Cronus Pharma Specialities India has 5 deals on record (3 rights issues, 1 funding round, 1 secondary share transfer), with disclosed funding of ₹98.39 Cr; the latest was in May 2022.
The peers of Cronus Pharma Specialities India by revenue are Maneesh Pharmaceuticals Limited, Mapaex Health and Personalcare Private Limited, Syncom Formulations (India) Limited, Karnataka Antibiotics and Pharmaceuticals Limited, Cachet Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Muralikrishna Prasad Vallabhaneni ceased to be Additional Director on 29 Sep 2024. Muralikrishna Prasad Vallabhaneni was appointed as Director on 26 Feb 2024. Bhaskar Rao Vamsi Krishna Velaga ceased to be Additional Director on 30 Sep 2019. Cronus Pharma Specialities India has 7 board changes on record in total.
Cronus Pharma Specialities India has 12 MSME Form 1 returns on record between 2019 and 2024, listing 173 overdue payments to 15 micro and small suppliers. The latest return was filed on 30 Apr 2024.
Cronus Pharma Specialities India can be reached through the website cronuspharma.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Cronus Pharma Specialities India is at Unit 26B 19th Floor The Headquarters Orbit, Plot No 30C Sy No 831 Hyderabad Knowledge City Raidurg Serilingampally Mandal, Telangana, India – 500081.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
